Drugs / Neocartilage Implant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01400607 Comparator | Jul 2011 → Sep 2020 | articular cartilage disorder, osteoarthritis | ISTO Technologies, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neocartilage Implant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01400607 ↗ |
| Known as | DeNovo ET | “Neocartilage Implant/DeNovo® ET (Engineered Tissue Graft)” NCT01400607 ↗ |
| Modality | Cell therapy | “cultured from juvenile human cartilage cells” NCT01400607 ↗ |